Lipid soluble radioactive metal chelates for tumor therapy
AssigneeThomas Jefferson University
InventorMadhukar (Mathew) L. Thakur
Life of this patent
Estimating the term…
Abstract
The present invention is a method of injecting a class of lipid soluble radioactive metal chelate compounds for intratumoral treatment of malignant, benign, metastatic, or inoperable tumors.
Claims7
A method of treating a tumor in a mammal, comprising injecting into a tumor a therapeutically effective amount of a lipid soluble radioactive metal chelate consisting of Indium-111-oxine or Indium-111-merc to arrest tumor cell proliferation.
A method of treating a prostate tumor in a mammal, comprising injecting into a tumor a therapeutically effective amount of a lipid soluble radioactive metal chelate consisting of Indium-111-oxine or Indium-111-merc to arrest prostate tumor cell proliferation.
A method of treating an inoperable tumor in a mammal, comprising injecting into a tumor a therapeutically effective amount of a lipid soluble radioactive metal chelate consisting of Indium-111-oxine or Indium-111-merc to arrest inoperable tumor cell proliferation.
A method of treating a brain tumor in a mammal, comprising injecting into a tumor a therapeutically effective amount of a lipid soluble radioactive metal chelate consisting of Indium-111-oxine or Indium-111-merc to arrest brain tumor tumor cell proliferation.
A method of treating a hepatoma in a mammal, comprising administering a injecting into a tumor a therapeutically effective amount of a lipid soluble radioactive metal chelate consisting of Indium-111-oxine or Indium-111-merc to arrest hepatoma cell proliferation.
A method of treating a melanoma in a mammal, comprising administering a injecting into a tumor a therapeutically effective amount of a lipid soluble radioactive metal chelate consisting of Indium-111-oxine or Indium-111-merc to arrest melanoma cell proliferation.
A method of treating a metastatic tumor in a mammal, comprising administering a injecting into a tumor a therapeutically effective amount of a lipid soluble radioactive metal chelate consisting of Indium-111-oxine or Indium-111-merc to arrest metastatic tumor cell proliferation.
Dependencies are inferred from the claim text.